Mirabel Mariana

[European Society of Cardiology @escardio]

Breakthroughs await! 🤗

Join Franz Weidinger and the other brilliant minds from across disciplines meeting at ESC Cardio-Oncology 2026 (19–20 June, Vienna, Austria).

It’s where you’ll learn and connect – and contribute to the solutions changing the future of cardio-oncology.

See you in Vienna at #ESCardioOnco26! https://t.co/DSUqGM0nSV

#cardioonc #cardioonco #oncology #radiology @ESCardioOnco

[Clara Llamedo, MD @LlamedoClara]

Delighted to join the 3rd edition of the COOL Podcast with Prof Ameri, discussing a common and clinically relevant challenge in daily practice. Join us at ESC Cardio-Oncology conference in Vienna for this topic and much more! #ESCardioOnco26

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Education, collaboration & implementation are key in #CardioOncology

📚#ESCardioOnco Certification Programme & Exam:
🔗 https://t.co/KBHjJokZFa

Join the growing global #cardiooncology community in Vienna this June:
🔗 https://t.co/P0o8QV30NH

@escardio

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

#CardioOncology is getting increasingly complex

What should the next guideline cycle deliver?

📍Risk prediction tools
📍Personalized CV prevention & monitoring
📍CV endpoints in oncology trials
📍Survivorship pathways
📍Access beyond expert centres
📍Measurable patient impact

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🎙️🚨New Podcast Alert!
How can cancer therapy impact blood pressure and vascular health?🩺❤️‍🩹
In our latest episode, Prof. Pietro Ameri 🇮🇹 and @LlamedoClara🇬🇧dive into “Hypertension and Vascular Toxicity in Cancer Therapy” #CardioOncology @ESC_Lavinia @TeresaLpezFdez1

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Fantastic joint session FAC-ESC at the XLIII Congreso Nacional de Cardiología!

A great multidisciplinary discussion highlighting how #CardioOncology is evolving across prevention, monitoring, survivorship & HF care, a 🧵👇

@escardio @fac_cardio

[European Society of Cardiology @escardio]

Your next step in #CardioOncology starts in Vienna, 19–20 June 🪜⬆️  

Unmissable onsite opportunities. Real impact on patient care.  

Join us at #ESCardioOnco26 — take the leap. 🌟https://t.co/Ec4REvuFxj

#cardioonc #cardioonco #oncology #radiology
@ESCardioOnco

[Clara Llamedo, MD @LlamedoClara]

The second episode of the podcast is now live - covering a highly relevant topic, especially given how often we see patients on HER2-targeted therapies!

@Massimi78530343
@JLiu_MSKCardOnc

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Why is #ESCardioOnco26 in Vienna so special?🫀

Professor Jutta Bergler-Klein @BerglerKlein, local host of the congress, highlights the fantastic science & multidisciplinary sessions.

⏳ Late fee ends 19/5/26!
Register now: https://t.co/P0o8QV30NH

#CardioOncology @escardio

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🎧 How should we monitor the heart during HER2+ breast cancer therapy?

In this ESC CardioOncology #CardioTalk, Dr @Massimi78530343 & Dr @JLiu_MSKCardOnc discuss about HER2 cardiotoxicity, risk stratification, & monitoring to prevent #CTRCD

🎧: https://t.co/fFm35VsKQW

[European Society of Cardiology @escardio]

#ESCardioOnco26 doesn’t follow innovation – it anticipates it ⏩

Next month, cardiologists, oncologists, haematologists, radiotherapists and allied professionals from around the world will come together to shape what’s next in cardio-oncology. Discover a programme offering a 360° view of the field and register by 19 May to save 👉 https://t.co/DSUqGM0nSV

@TeresaLpezFdez1 @slumberbell @DrRaulCordoba @BerglerKlein @FarmakisD @CiroSantoro17 @ESCardioOnco #ESCCardioOnco

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🌍 The ESC Council of Cardio-Oncology #CardioOnc at #HFA2026 in beautiful Barcelona🇪🇸 New projects, new research and new initiatives shaping the future 🚀
📍Want to know more? Join the Council and take part in the Vienna Congress in June 2026🇦🇹

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Ahead of World Cancer Day (4 Feb) 🗓️ we’re spotlighting our Top 10 #CardioOnc articles📚—showcasing the field’s momentum, collaboration🤝🫀and the power of multidisciplinary care. Stay tuned! 🚀 https://t.co/WWtctdgjjD #ESCardioOnco26

[Novi Yanti Sari @slumberbell]

🫀Can a patient with #HeartFailure still receive #anthracycline therapy?

Excellent & highly practical overview by @TeresaLpezFdez1 @ESCardioOnco at #HeartFailure26:

��The heart-cancer connection goes far beyond CTR-CVT, HF & cancer share: common risk factors & pathways.

📍Before saying “yes” or “no” to #anthracyclines, ask 4 key questions:
- What is the HF phenotype?
- What is the cancer priority/prognosis?
- Are effective non-anthracycline alternatives available?
- Can we reduce & closely monitor CV risk?

📍Anthracyclines are not always absolutely contraindicated in HF.
Some patients may still proceed with:
- optimized HF therapy
- intensive surveillance
- cardioprotection strategies
- modified regimens

📍Management must be multidisciplinary.
The goal is balancing cancer outcomes & cardiovascular outcomes ⚖️

📍Sometimes the answer is:
✅ yes
⚠️ yes, with modification & close monitoring
❌ or no/alternative strategy

📍A really important reminder that modern cardio-oncology is no longer about simply stopping cancer therapy, but individualizing risk while preserving both cardiac & oncologic outcomes

#CardioOncology @escardio

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🎙️The 1st episode of ESC CardioTalk: Cardio-Oncology is now LIVE🫀🩺
‘Which Patients Should Receive Pre-Treatment Cardiac Screening Before Chemotherapy or Immunotherapy?’
Discover expert insights and stay updated with the latest discussions🌍
👉Listen now https://t.co/YvILtCLtBf

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Why join #ESCardioOnco26 in Vienna?
A true 360° view of #cardiooncology, cutting-edge science + real-world care.
- Practical, case-based sessions
- Tracks for all levels
- Focus on prevention & survivorship

⏳ Early reg ends 22 April
Register now: https://t.co/P0o8QV30NH

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Excellent #EAPCI & #ESCCardioOnco joint session on #PCI in patients w/ cancer & ACS #EAPCI26

Clinical decisions must balance ischemic risk, bleeding risk & cancer prognosis.

Want to learn more?
Join #ESCardioOnco26 in Vienna,
19-20 June 26: https://t.co/P0o8QV30NH

@escardio

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Join us for the #ESCCardioOnco Webinar🔔
CARDIOCARE: Digital & Imaging Strategies in Breast Cancer

16 February 2026 | 18:00-19:30 CET

Faculty: Drs. #ManolisTsiknakis, #AnastasiaConstantinidou, #DimitriosFotiadis, #KettiMazzocco, @drmirabel

Register ➡️
https://t.co/5EM3dCjk3h

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🌍Cardio-Oncology at the Heart of Cancer Care
The ESC CRT on #CardioOncology just concluded—with academia, regulators, industry & patients to shape a roadmap for CV safety,monitoring& survivorship.
Next stop➡️Vienna🇦🇹at #ESCardioOnco2026 to keep the momentum going. Don’t miss it!

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

More time to make an impact in #cardiooncology

📣 Abstract deadline extended for #ESCardioOnco26!

Abstracts: 3 Feb 26
Clinical cases: 5 Feb 26

Join the global cardio-oncology community in Vienna, 19-20 June: https://t.co/B41EGhERSV

#ESCCardioOnco @TeresaLpezFdez1